The influence of high-dose systemic zoledronate administration on osseointegration of implants with different surface topography

Aim To evaluate the influence of systemic zoledronate administration on the osseointegration of titanium implants with different surface topography in rat maxillae. Methods Twenty Sprague-Dawley rats were divided into two groups-test (bisphosphonate) and control (healthy). Bisphosphonate administration began three weeks prior to implant placement, and the animals received zoledronate (66 mu g/kg) three times per week. Forty endosseous implants with a moderately rough (20 implants) or a turned surface (20 implants) were immediately placed bilaterally into extraction sockets of maxillary first molars. Animals were sacrificed after 14 and 28 days of healing, and en bloc specimens were harvested for histological and histomorphometric analysis. Osseointegration was quantified by measuring the percentage of bone-to-implant contact. Results Bone-to-implant contact (BIC) (mean +/- SD) values of moderately rough and turned implants at day 14 in test group were 17.62 +/- 6.68 and 10.69 +/- 1.48, respectively, while in the control group, they were 46.36 +/- 5.08 and 33.29 +/- 8.89, respectively. At day 28, BIC values of moderately rough and turned implants in the test group were 25.94 +/- 7.87 and 7.83 +/- 4.30, respectively, while in the control group, they were 72.99 +/- 6.60 and 47.62 +/- 18.19, respectively. Statistically significant higher BIC values were measured on moderately rough implants compared to turned implants at 28 days, and the control group compared to the test group for both implant surfaces. Histological observations for the control and the test groups demonstrated initial bone formation around moderately rough implants not only on the surface of the parent bone, as was the case with the turned surfaced implants, but also along the implant surface itself. Conclusions Systemic zoledronate administration negatively influences osseointegration. Osseointegration was enhanced adjacent to moderately rough compared to turned implants in both the presence and absence of systemic zoledronate administration. Therefore, topographical surface modification may partially offset the negative impact of zoledronate administration.